Concepedia

Publication | Open Access

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas

DOIFull Paper Access

118

Citations

27

References

2010

Year

Fábio M. Iwamoto, Teri Kreisl, Lyndon Kim, J. Paul Duic, John A. Butman, Paul S. Albert, Howard A. Fine
Cancer

Abstract

: Talampanel was well-tolerated but had no significant activity as a single agent in unselected recurrent malignant gliomas. Cancer 2010. Published 2010 by the American Cancer Society.

References

YearCitations

Page 1